Health

Results: 121-132 of 4670

Sangamo Therapeutics Announces Updated Phase 1/2 STAAR Study Data in Fabry Disease Showing Sustained Benefit, Improvements in Kidney Function and Favorable Safety Profile

Henlius and Dr. Reddy's Ink Licensing Deal for HLX15 (investigational daratumumab biosimilar) Expansion in Europe and the U.S.

Broken String Biosciences Launches Catalyst Program to Shorten Gene Editing Therapy Development by Months

PR Newswire associated0

Stax Appoints Adam Thorpe as Managing Director to Lead EMEA Healthcare Vertical and Drive Expansion in UK and European Markets

PR Newswire associated0

Inizio accelerates growth with a trio of strategic leadership appointments

PR Newswire associated0

Accord Healthcare: Hetronifly® (Serplulimab) receives Marketing Authorisation from the European Commission (EC), for the treatment of Extensive-Stage Small Cell Lung Cancer (ES- SCLC)

Wyss Center Partners with BrainScape Medical to License Groundbreaking Epios® Technology

Implantica announces onboarding of the world-leading La Paz University Hospital, Spain

Hansa Biopharma Reports Fourth Quarter and Full Year 2024 Financial Results

PR Newswire associated0

AttoSure Achieves Prestigious ISO Certifications, Cementing Its Position as a Leading Drug and Alcohol Testing Laboratory in the UK

Proposed Delisting via Merger of BenevolentAI into Osaka Holdings S.à r.l. and Publication of Notice of Extraordinary General Meeting

New England Journal of Medicine Publishes: Efficacy of Zenocutuzumab in NRG1 Fusion-Positive Cancer